Spore.Bio raises $23M to apply machine learning to microbiology testing | TechCrunch
Briefly

Spore.Bio is a Paris-based deeptech startup that recently raised $23 million in Series A funding to innovate microbiology testing for the food and beverage industry. With rising customer demand and existing contracts covering up to 200 factories, the company is seeking to reduce the lengthy testing times currently required for microbiological safety. Traditional testing takes several days due to the need for samples to be sent to labs and incubated, which can bring production to a standstill. Spore.Bio's approach aims to streamline this process dramatically.
Recalls in the food and beverage industry due to contamination incidents can have catastrophic effects.
Spore.Bio, a Paris-based deeptech startup, is trying to reinvent microbiology testing to avoid the next PR crisis in the food industry.
Spore.Bio managed to raise so quickly after its pre-seed round is that there's real customer interest.
In the food and beverage industry, microbiological tests require several days, but Spore.Bio's technology aims to optimize this process.
Read at TechCrunch
[
|
]